Two department members were awarded Engebretson Drug Design and Development grants: Rory Remmel, Distinguished Teaching Professor, for his "Meropenem prodrugs for treatment of tuberculosis" project, and Michael Walters, ITDD Director of Lead and Probe Discovery, for his "Enhancers of dihydrolipoamide dehydrogenase stability and function."